Rezular

Arverapamil · AGI Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rezular, covering 2009-06-11 to 2009-06-11. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy Study of Rezular (Arverapamil) in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D) [Phase 3]

See pricing